Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
about
Process of Fragment-Based Lead Discovery-A Perspective from NMRNMR Fragment Screening Hit Induces Plasticity of BRD7/9 BromodomainsA Chemical Probe for the ATAD2 BromodomainStructure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signalingProgress in the Development of non-BET Bromodomain Chemical Probes.Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology.Structural features and inhibitors of bromodomains.Bromodomain inhibitors and cancer therapy: From structures to applications.Synthesis and Demonstration of the Biological Relevance of sp3 -rich Scaffolds Distantly Related to Natural Product Frameworks.Chemical probes and inhibitors of bromodomains outside the BET family.ATAD2 in cancer: a pharmacologically challenging but tractable target.The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes.The identification of new ATAD2 bromodomain inhibitors: the application of combined ligand and structure-based virtual screening.Patent Highlights June-July 2017.Identifying Small-Molecule Binding Sites for Epigenetic Proteins at Domain-Domain Interfaces.Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple).A Chemical Probe for the ATAD2 Bromodomain
P2860
Q26738768-E74ACE24-B2D4-4111-A97B-F8D1C921FAFFQ27704896-B26EE796-1F7E-4C9B-9630-F6B5940945F9Q27727700-61BDE100-758B-457F-9085-5E1AABCF54EEQ35885359-7228F2A3-C57E-46D8-859D-351E1C362EA0Q36561575-86E2043D-091F-4063-9034-2DA52B6E7B1CQ38691377-22374008-F48B-457E-A2AC-7C7E57AFA72CQ38707876-557979A2-A8FE-41E6-81BD-D0FC8461921EQ38837561-BDBB0B51-036D-4242-8C9B-AD9DAD636381Q38987705-FF13B8B7-60C9-486D-AFB4-FF5B7DC9C976Q39027056-19A6048D-2811-4531-B9F4-9339E87FE8F9Q47099492-CC42A204-33A8-4AF4-B54A-F7D9389C763CQ47128083-289ED763-3C60-4AB8-BFE3-475B313EAE69Q47392240-3827E760-0C30-4A2B-916B-6058E52CDB89Q47554095-95900141-1B45-4B38-9C0A-5D79FABA1EDEQ49483734-9152C7C8-0AC6-4550-BB1A-9910447E8143Q50075584-3571E898-66D7-4AFB-B98D-8D513C5B68CAQ52631343-5887EEAC-CF04-49B6-8BCF-98EC4FE31556Q52659146-638B1009-05FC-4F24-8DF6-792C3F8E98EAQ57888571-B1109523-DEBB-433D-83A6-1EF5CAF7AD61
P2860
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
@ast
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
@en
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
@nl
type
label
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
@ast
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
@en
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
@nl
prefLabel
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
@ast
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
@en
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
@nl
P2093
P3181
P1476
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
@en
P2093
Amanda J Emmons
Andy D Roberts
Angela M Bridges
Bernadette H Mouzon
Bhumika V Karamshi
Chris Wellaway
Chun-wa Chung
Clement Douault
Darren J Mitchell
David P Dixon
P304
P3181
P356
10.1021/ACS.JMEDCHEM.5B00772
P407
P577
2015-07-23T00:00:00Z